Cotriptyline

This classification denotes an antidepressant agent with the molecular formula C20H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KQJ4QI511C, chemically known as 1-(dimethylamino)-3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-2-propanone but generally known as cotriptyline, which bears US NIH Compound Identifier 71935. European Medicines Agency schedules Cotriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06812MIG. The term COTRIPTYLINE is an International Non-Proprietary Name. COTRIPTYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cotriptyline under HS 29223900 and SITC 51463. As of Q4 2014, COTRIPTYLINE remains the US FDA Preferred Term for this commodity. Cotriptyline bears US NLM identifiers UMLS ID C0600943 and NCI Concept Code C78004. SMILES: O=C(/C=C1/c2c(CCc3c1cccc3)cccc2)CN(C)C.